AU2020279752A1 - Systems and methods for evaluating tumor fraction - Google Patents

Systems and methods for evaluating tumor fraction Download PDF

Info

Publication number
AU2020279752A1
AU2020279752A1 AU2020279752A AU2020279752A AU2020279752A1 AU 2020279752 A1 AU2020279752 A1 AU 2020279752A1 AU 2020279752 A AU2020279752 A AU 2020279752A AU 2020279752 A AU2020279752 A AU 2020279752A AU 2020279752 A1 AU2020279752 A1 AU 2020279752A1
Authority
AU
Australia
Prior art keywords
tumor
sample
allele
fraction
coverage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2020279752A
Other languages
English (en)
Inventor
Bernard FENDLER
Jason D. HUGHES
Steven Roels
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Foundation Medicine Inc
Original Assignee
Foundation Medicine Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Foundation Medicine Inc filed Critical Foundation Medicine Inc
Publication of AU2020279752A1 publication Critical patent/AU2020279752A1/en
Priority to AU2025271452A priority Critical patent/AU2025271452A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20—Supervised data analysis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/10—Ploidy or copy number detection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medical Informatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Data Mining & Analysis (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Evolutionary Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Databases & Information Systems (AREA)
  • Bioethics (AREA)
  • Evolutionary Computation (AREA)
  • Artificial Intelligence (AREA)
  • Software Systems (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Biomedical Technology (AREA)
  • Primary Health Care (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2020279752A 2019-05-20 2020-05-20 Systems and methods for evaluating tumor fraction Abandoned AU2020279752A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2025271452A AU2025271452A1 (en) 2019-05-20 2025-11-27 Systems and methods for evaluating tumor fraction

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962850474P 2019-05-20 2019-05-20
US62/850,474 2019-05-20
PCT/US2020/033821 WO2020236941A1 (en) 2019-05-20 2020-05-20 Systems and methods for evaluating tumor fraction

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2025271452A Division AU2025271452A1 (en) 2019-05-20 2025-11-27 Systems and methods for evaluating tumor fraction

Publications (1)

Publication Number Publication Date
AU2020279752A1 true AU2020279752A1 (en) 2022-01-06

Family

ID=73458622

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2020279752A Abandoned AU2020279752A1 (en) 2019-05-20 2020-05-20 Systems and methods for evaluating tumor fraction
AU2025271452A Pending AU2025271452A1 (en) 2019-05-20 2025-11-27 Systems and methods for evaluating tumor fraction

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2025271452A Pending AU2025271452A1 (en) 2019-05-20 2025-11-27 Systems and methods for evaluating tumor fraction

Country Status (11)

Country Link
US (2) US20220243279A1 (https=)
EP (1) EP3973530A4 (https=)
JP (1) JP7702360B2 (https=)
KR (1) KR20220011140A (https=)
CN (1) CN114026646A (https=)
AU (2) AU2020279752A1 (https=)
BR (1) BR112021022879A2 (https=)
CA (1) CA3140066A1 (https=)
IL (1) IL288182A (https=)
SG (1) SG11202111947PA (https=)
WO (1) WO2020236941A1 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES3022582T3 (en) 2013-05-10 2025-05-28 Found Medicine Inc Analysis of genetic variants
JP2023552391A (ja) * 2020-12-03 2023-12-15 ファウンデーション・メディシン・インコーポレイテッド 治療を選択し、予想される治療転帰を判定するための木ベースのモデル
EP4266315A4 (en) * 2020-12-16 2024-11-20 Seedna Inc. METHOD FOR CALCULATING THE RELIABILITY VALUE OF A POLYMORPHISM LOCUS SIGNAL
CN113025716A (zh) * 2021-03-02 2021-06-25 北京大学第一医院 一种用于人肿瘤分级的基因组合及其用途
WO2022271159A1 (en) * 2021-06-22 2022-12-29 Foundation Medicine, Inc. Systems and methods for evaluating tumor fraction
EP4374376A4 (en) * 2021-07-23 2025-05-28 Foundation Medicine, Inc. METHODS FOR DETERMINING VARIANT FREQUENCY AND MONITORING DISEASE PROGRESSION
JP2024538725A (ja) * 2021-10-08 2024-10-23 ファウンデーション・メディシン・インコーポレイテッド コピー数変化呼び出しに対する汚染を検出及び除去するための方法及びシステム
EP4430614A4 (en) * 2021-11-12 2025-12-17 Found Medicine Inc Circulating tumor DNA fraction and uses thereof
WO2023096658A1 (en) * 2021-11-23 2023-06-01 Foundation Medicine, Inc. Methods and systems for reporting clinically-actionable potential germline pathogenic variant sequences
US20250037823A1 (en) 2021-12-08 2025-01-30 Foundation Medicine, Inc. Methods and systems for highlighting clinical information in diagnostic reports
CN114530200B (zh) * 2022-03-18 2022-09-23 北京阅微基因技术股份有限公司 基于计算snp熵值的混合样本鉴定方法
CN119585730A (zh) * 2022-07-15 2025-03-07 基金会医学公司 用于确定患者样品中循环肿瘤dna分数的方法和系统
WO2024081859A2 (en) * 2022-10-14 2024-04-18 Foundation Medicine, Inc. Methods and systems for performing genomic variant calls based on identified off-target sequence reads
WO2024112967A1 (en) * 2022-11-27 2024-05-30 The University Of Chicago Methods for treating cancer with immunotherapy
EP4631049A4 (en) * 2022-12-09 2026-02-18 Found Medicine Inc METHODS AND SYSTEMS FOR DETERMINING THE CLONALITY OF SOMATIC SHORT VARIANTS
CN121219428A (zh) * 2023-05-15 2025-12-26 基金会医学公司 用于评定液体活检样品中循环肿瘤dna分数的方法和系统
WO2024238750A2 (en) * 2023-05-17 2024-11-21 Foundation Medicine, Inc. Clonal hematopoiesis burden as a biomarker for immune checkpoint inhibitor response
WO2025054202A1 (en) 2023-09-05 2025-03-13 Sana Biotechnology, Inc. Method of screening a sample comprising a transgene with a unique barcode
WO2025151838A1 (en) 2024-01-12 2025-07-17 Sana Biotechnology, Inc. Safety switches to control in vitro and in vivo proliferation of cell therapy products
CN121305088B (zh) * 2025-12-09 2026-03-17 中国人民解放军空军军医大学 迁移学习驱动的颅内肿瘤影像数据全自动分割方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110301854A1 (en) * 2010-06-08 2011-12-08 Curry Bo U Method of Determining Allele-Specific Copy Number of a SNP
WO2014014498A1 (en) * 2012-07-20 2014-01-23 Verinata Health, Inc. Detecting and classifying copy number variation in a fetal genome
US11261494B2 (en) * 2012-06-21 2022-03-01 The Chinese University Of Hong Kong Method of measuring a fractional concentration of tumor DNA
CA2945962C (en) * 2014-04-21 2023-08-29 Natera, Inc. Detecting mutations and ploidy in chromosomal segments
WO2015164432A1 (en) * 2014-04-21 2015-10-29 Natera, Inc. Detecting mutations and ploidy in chromosomal segments
HUE058263T2 (hu) * 2015-02-10 2022-07-28 Univ Hong Kong Chinese Mutációk detektálása rákszûrési és magzatelemzési célból
BR112018005940A2 (pt) * 2015-09-25 2018-12-11 Contextual Genomics Inc métodos de garantia da qualidade molecular para uso em sequenciamento
CN114959918A (zh) * 2016-02-29 2022-08-30 基础医疗股份有限公司 用于评估肿瘤突变负荷的方法和系统
CA3067419A1 (en) * 2017-06-20 2018-12-27 Illumina, Inc. Methods and systems for decomposition and quantification of dna mixtures from multiple contributors of known or unknown genotypes
JP7760242B2 (ja) * 2017-07-21 2025-10-27 ジェネンテック， インコーポレイテッド がんの治療法及び診断法

Also Published As

Publication number Publication date
CN114026646A (zh) 2022-02-08
JP7702360B2 (ja) 2025-07-03
EP3973530A1 (en) 2022-03-30
IL288182A (en) 2022-01-01
KR20220011140A (ko) 2022-01-27
US20220243279A1 (en) 2022-08-04
BR112021022879A2 (pt) 2022-03-22
AU2025271452A1 (en) 2026-01-29
WO2020236941A1 (en) 2020-11-26
JP2022533137A (ja) 2022-07-21
CA3140066A1 (en) 2020-11-26
SG11202111947PA (en) 2021-12-30
US20250259709A1 (en) 2025-08-14
EP3973530A4 (en) 2023-08-02

Similar Documents

Publication Publication Date Title
JP7702360B2 (ja) 腫瘍分率を評価するためのシステムおよび方法
JP2024112843A (ja) ゲノム変化を評価するための組成物および方法
CN109196359B (zh) 用于评估肿瘤突变负荷的方法和系统
EP4359569A1 (en) Systems and methods for evaluating tumor fraction
EP3766986B1 (en) Detection and treatment of disease exhibiting disease cell heterogeneity and systems and methods for communicating test results
US20250131981A1 (en) Methods and systems for determining microsatellite instability
US20230162815A1 (en) Methods and systems for accurate genotyping of repeat polymorphisms
EP4427226A1 (en) System and method for identifying copy number alterations
US20250037823A1 (en) Methods and systems for highlighting clinical information in diagnostic reports
US20240412812A1 (en) Methods and systems for detecting and removing contamination for copy number alteration calling
US20240420799A1 (en) Methods and systems for predicting the reliability of somatic/germline calls for variant sequences
US20240404626A1 (en) Methods and systems for automated calling of copy number alterations
US20250014678A1 (en) Methods and systems for reporting clinically-actionable potential germline pathogenic variant sequences
HK40075645A (en) Method and system for assessing tumor mutation load
HK40002957B (en) Methods and systems for evaluating tumor mutational burden
HK40002957A (en) Methods and systems for evaluating tumor mutational burden

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted